116 related articles for article (PubMed ID: 22648765)
1. The concept of prenatal gene therapy.
Coutelle C; Waddington SN
Methods Mol Biol; 2012; 891():1-7. PubMed ID: 22648765
[TBL] [Abstract][Full Text] [Related]
2. Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application.
Coutelle C; Ashcroft R
Methods Mol Biol; 2012; 891():371-87. PubMed ID: 22648781
[TBL] [Abstract][Full Text] [Related]
3. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
[TBL] [Abstract][Full Text] [Related]
4. Vector systems for prenatal gene therapy: choosing vectors for different applications.
Coutelle C; Waddington SN
Methods Mol Biol; 2012; 891():41-53. PubMed ID: 22648767
[TBL] [Abstract][Full Text] [Related]
5. Animal models for prenatal gene therapy: the sheep model.
Abi-Nader KN; Boyd M; Flake AW; Mehta V; Peebles D; David AL
Methods Mol Biol; 2012; 891():219-48. PubMed ID: 22648775
[TBL] [Abstract][Full Text] [Related]
6. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
7. Vector systems for prenatal gene therapy: principles of non-viral vector design and production.
Wong SP; Argyros O; Harbottle RP
Methods Mol Biol; 2012; 891():133-67. PubMed ID: 22648771
[TBL] [Abstract][Full Text] [Related]
8. Animal models for prenatal gene therapy: choosing the right model.
Mehta V; Peebles D; David AL
Methods Mol Biol; 2012; 891():183-200. PubMed ID: 22648773
[TBL] [Abstract][Full Text] [Related]
9. Stem cell and genetic therapies for the fetus.
Roybal JL; Santore MT; Flake AW
Semin Fetal Neonatal Med; 2010 Feb; 15(1):46-51. PubMed ID: 19540822
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
[TBL] [Abstract][Full Text] [Related]
11. On the scientific and ethical issues of fetal somatic gene therapy.
Coutelle C; Rodeck C
Gene Ther; 2002 Jun; 9(11):670-3. PubMed ID: 12032684
[TBL] [Abstract][Full Text] [Related]
12. Vector systems for prenatal gene therapy: principles of retrovirus vector design and production.
Howe SJ; Chandrashekran A
Methods Mol Biol; 2012; 891():85-107. PubMed ID: 22648769
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
14. Candidate diseases for prenatal gene therapy.
David AL; Waddington SN
Methods Mol Biol; 2012; 891():9-39. PubMed ID: 22648766
[TBL] [Abstract][Full Text] [Related]
15. Animal models for prenatal gene therapy: the nonhuman primate model.
Mattar CN; Biswas A; Choolani M; Chan JK
Methods Mol Biol; 2012; 891():249-71. PubMed ID: 22648776
[TBL] [Abstract][Full Text] [Related]
16. In utero gene therapy: current challenges and perspectives.
Waddington SN; Kramer MG; Hernandez-Alcoceba R; Buckley SM; Themis M; Coutelle C; Prieto J
Mol Ther; 2005 May; 11(5):661-76. PubMed ID: 15851005
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
18. An introduction to gene therapy and its potential prenatal use.
Staff AC
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):485-91. PubMed ID: 11380282
[TBL] [Abstract][Full Text] [Related]
19. Choice of surrogate and physiological markers for prenatal gene therapy.
Delhove JM; Rahim AA; McKay TR; Waddington SN; Buckley SM
Methods Mol Biol; 2012; 891():273-90. PubMed ID: 22648777
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.
Vigna E; Naldini L
J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
